Authors: Ruotsalainen, T Halme, M Isokangas, OP Pyrhonen, S Mantyla, M Pekonen, M Sarna, S Joensuu, H Mattson, K

Citation: T. Ruotsalainen et al., Interferon-alpha and 13-cis-retinoic acid as maintenance therapy after high-dose combination chemotherapy with growth factor support for small cell lung cancer - a feasibility study, ANTI-CANC D, 11(2), 2000, pp. 101-108

Authors: Cser, L Cselenyi, J Geiger, M Mantyla, M Korhonen, AS

Citation: L. Cser et al., Logistics from IMS towards virtual factory, J MATER PR, 103(1), 2000, pp. 6-13

Authors: Ruotsalainen, TM Halme, M Tamminen, K Szopinski, JN Niiranen, A Pyrhonen, S Riska, H Maasilta, P Jekunen, A Mantyla, M Kajanti, M Joensuu, H Sarna, S Cantell, K Mattson, K

Citation: Tm. Ruotsalainen et al., Concomitant chemotherapy and IFN-alpha for small cell lung cancer: A randomized multicenter phase III study, J INTERF CY, 19(3), 1999, pp. 253-259

Authors: Isokangas, OP Knuuttila, A Halme, M Mantyla, M Lindstrom, I Nikkanen, V Viren, M Joensuu, H Mattson, K

Citation: Op. Isokangas et al., Phase II study of vinorelbine and gemcitabine for inoperable stage IIIB-IVnon-small-cell lung cancer, ANN ONCOL, 10(9), 1999, pp. 1059-1063

Authors: Mantyla, M Rossoll, A Nedbal, I Prioul, C Marini, B

Citation: M. Mantyla et al., Fractographic observations of cleavage fracture initiation in a bainitic A508 steel, J NUCL MAT, 264(3), 1999, pp. 257-262

Authors: Halme, M Knuuttila, A Vehmas, T Tammilehto, L Mantyla, M Salo, J Mattson, K

Citation: M. Halme et al., High-dose methotrexate in combination with interferons in the treatment ofmalignant pleural mesothelioma, BR J CANC, 80(11), 1999, pp. 1781-1785